CATHEDRA BITCOIN INC
CBTTF
Abits
ABTS
NEPTUNE DIGITAL ASSETS CORP
NPPTF
BIGG DIGITAL ASSETS INC
BBKCF
DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
Updated: Dec 26, 2024
The average Revance Therapeutics stock price target is 6.75 with a max estimate of 7.00 and a min estimate of 6.60
Review Revance Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Dec 26, 2024